期刊
CHEMICO-BIOLOGICAL INTERACTIONS
卷 337, 期 -, 页码 -出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.cbi.2021.109396
关键词
Long noncoding RNAs; Aging kidney; Kidney disease; Diabetic nephropathy; Renal fibrosis; Biomarker
资金
- Shaanxi Key Science and Technology Plan Project [2019ZDLSF04-04-02]
- National Natural Science Foundation of China [82074002, 81872985]
Aging is a risk factor for chronic diseases, including kidney disease. Advances in genome analyses have identified noncoding RNAs, specifically lncRNAs, that play critical roles in the regulation of gene expression and epigenetic reprogramming, and have been shown to be important in kidney disease. Targeting lncRNAs may present a precise therapeutic strategy for progressive renal fibrosis.
Aging as one of intrinsic biological processes is a risk factor for many chronic diseases. Kidney disease is a global problem and health care burden worldwide. The diagnosis of kidney disease is currently based on serum creatinine and urea levels. Novel biomarkers may improve diagnostic accuracy, thereby allowing early prevention and treatment. Over the past few years, advances in genome analyses have identified an emerging class of noncoding RNAs that play critical roles in the regulation of gene expression and epigenetic reprogramming. Long noncoding RNAs (lncRNAs) are pervasively transcribed in the genome and could bind DNA, RNA and protein. Emerging evidence has demonstrated that lncRNAs played an important role in all stages of kidney disease. To date, only some lncRNAs were well identified and characterized, but the complexity of multilevel regulation of transcriptional programs involved in these processes remains undefined. In this review, we summarized the lncRNA expression profiling of large-scale identified lncRNAs on kidney diseases including acute kidney injury, chronic kidney disease, diabetic nephropathy and kidney transplantation. We further discussed a number of annotated lncRNAs linking with complex etiology of kidney diseases. Finally, several lncRNAs were highlighted as diagnostic biomarkers and therapeutic targets. Targeting lncRNAs may represent a precise therapeutic strategy for progressive renal fibrosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据